Convalescent Plasma News and Research

RSS
Study examines motivations and barriers to convalescent plasma donation in the UK

Study examines motivations and barriers to convalescent plasma donation in the UK

Why SARS-CoV-2 B.1.1.7 is more virulent

Why SARS-CoV-2 B.1.1.7 is more virulent

India's Covaxin vaccine likely effective against UK SARS-CoV-2 variant: Study

India's Covaxin vaccine likely effective against UK SARS-CoV-2 variant: Study

Variants emerging during COVID-19 pandemic resist antibody neutralization

Variants emerging during COVID-19 pandemic resist antibody neutralization

Ebola survivors experienced a resurgence in antibody levels after recovery

Ebola survivors experienced a resurgence in antibody levels after recovery

Antibodies and inflammatory markers may help identify COVID-19 cases and predict severity

Antibodies and inflammatory markers may help identify COVID-19 cases and predict severity

Infusion of convalescent blood plasma benefits patient with severe COVID-19

Infusion of convalescent blood plasma benefits patient with severe COVID-19

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Mapping antibody reactivity in COVID-19 patients by using multi-coronavirus protein microarray

Mapping antibody reactivity in COVID-19 patients by using multi-coronavirus protein microarray

Study predicts good passive immunotherapy donors to combat COVID-19

Study predicts good passive immunotherapy donors to combat COVID-19

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Synthetic lung organoids provide high-throughput platform to identify new cellular targets of SARS-CoV-2

Synthetic lung organoids provide high-throughput platform to identify new cellular targets of SARS-CoV-2

Single-dose nanoparticle COVID-19 vaccine elicits virus-neutralizing antibody response in mice

Single-dose nanoparticle COVID-19 vaccine elicits virus-neutralizing antibody response in mice

How do SARS-CoV-2 antibodies change over time in recovered patients?

How do SARS-CoV-2 antibodies change over time in recovered patients?

SARS-CoV-2 viral load in saliva may be linked to COVID-19 disease severity

SARS-CoV-2 viral load in saliva may be linked to COVID-19 disease severity

Anti-SARS-CoV-2 NTD-directed antibodies are protective against lethal infection

Anti-SARS-CoV-2 NTD-directed antibodies are protective against lethal infection

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality